This site is intended for healthcare professionals

Drug Database

Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.

Search (above) to find prescription medicines and other approved products by name of medicinal product, class, or therapeutic indication. Or browse the drug database by ATC classification.

Learning Zones

Chronic Kidney Disease Learning Zone
Learning Zone Homepage

Chronic Kidney Disease Learning Zone

310 mins
Molecular diagnostics for RET inhibition in NSCLC and thyroid cancers
Learning Zone Homepage

Molecular diagnostics for RET inhibition in NSCLC and thyroid cancers

270 mins
Hidradenitis suppurativa (HS) Learning Zone
Learning Zone Homepage

Hidradenitis suppurativa (HS) Learning Zone

200 mins
Multiple Sclerosis (MS) Learning Zone
Learning Zone

Multiple Sclerosis (MS) Learning Zone

250 mins
Food Allergy Learning Zone
Learning Zone Homepage

Food Allergy Learning Zone

190 mins
Atopic Dermatitis Learning Zone
Learning Zone Homepage

Atopic Dermatitis Learning Zone

335 mins
Cardiovascular Metabolism Learning Zone
Learning Zone

Cardiovascular Metabolism Learning Zone

365 mins
Major depressive disorder and treatment-resistant depression
Learning Zone Homepage

Major depressive disorder and treatment-resistant depression

195 mins
Inflammatory Bowel Disease Learning Zone
Learning Zone

Inflammatory Bowel Disease Learning Zone

100 mins
Transplantation Learning Zone
Learning Zone Homepage

Transplantation Learning Zone

730 mins
Innovations in MS care to improve individual disease management
Learning Zone

Innovations in MS care to improve individual disease management

145 mins
Cancer-Associated Thrombosis
Learning Zone

Cancer-Associated Thrombosis

135 mins
Diagnosis and management of primary hyperoxaluria type 1
Learning Zone

Diagnosis and management of primary hyperoxaluria type 1

110 mins
Improving treatment options for childhood psoriasis
Learning Zone Homepage

Improving treatment options for childhood psoriasis

270 mins
CDK4/6 inhibitors in breast cancer
Learning Zone

CDK4/6 inhibitors in breast cancer

160 mins
Managing Osteoarthritis-associated Pain
Learning Zone Homepage

Managing Osteoarthritis-associated Pain

265 mins
Fluid Management Learning Zone
Learning Zone Homepage

Fluid Management Learning Zone

225 mins
Anticoagulation Therapy for Stroke Prevention
Learning Zone Homepage

Anticoagulation Therapy for Stroke Prevention

500 mins
Respiratory Care
Learning Zone Homepage

Respiratory Care

490 mins
Optimising anti-TNF treatment using biosimilars
Learning Zone Homepage

Optimising anti-TNF treatment using biosimilars

85 mins
Fibrinogen Deficiency in Bleeding Learning Zone
Learning Zone Homepage

Fibrinogen Deficiency in Bleeding Learning Zone

160 mins
Idiopathic Pulmonary Fibrosis
Learning Zone Homepage

Idiopathic Pulmonary Fibrosis

140 mins
Oral Anticoagulation Reversal Learning Zone
Learning Zone Homepage

Oral Anticoagulation Reversal Learning Zone

355 mins
Psoriasis Learning Zone
Learning Zone Homepage

Psoriasis Learning Zone

440 mins
Psoriasis Academy
Learning Zone Homepage

Psoriasis Academy

910 mins
Sleep Apnea Learning Zone
Learning Zone Homepage

Sleep Apnea Learning Zone

295 mins
Hereditary ATTR Amyloidosis
Learning Zone Homepage

Hereditary ATTR Amyloidosis

120 mins
One Neuroscience and Pain Learning Zone
Learning Zone Homepage

One Neuroscience and Pain Learning Zone

830 mins
Acute Hepatic Porphyria Learning Zone
Learning Zone Homepage

Acute Hepatic Porphyria Learning Zone

45 mins
CSU Learning Zone
Learning Zone Homepage

CSU Learning Zone

890 mins

 

 

Disclaimer

The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.

Medthority will not be held liable for explicit or implicit errors, or missing data.

Reporting of suspected adverse reactions 

Drug Licencing

Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).